Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has awarded a grant of $35m to the National Institute for Pharmaceutical Technology and Education (NIPTE) to improve drug manufacturing standards in the upcoming five years.
Subscribe to our email newsletter
FDA intends to improve drug safety, cut health care costs and create jobs through this move.
The grant will support programs to rectify drug development and manufacturing problems.
In addition, the agency will enable new performance attributes, improve small-batch production, promote continuous manufacturing, save money and reduce environmental impact from the manufacturing of products.
Currently, the cost of bringing a drug to market in the US exceeds $1bn and an increasing number of drugs and drug ingredients are being imported from abroad.
Investment in research of drug development and manufacturing will improve the country’s manufacturing besides helping reverse the current outsourcing trends in the pharmaceutical industry.